Amgen Inc at Goldman Sachs Global Healthcare Conference Transcript
Good morning. Thanks, everyone, for joining us. Really pleased to have the Amgen team with us. We have Peter Griffith, CFO; and Dave Reese, Head of R&D. With that, earlier this year -- actually, I'm going to turn it over to you, Peter, first to start with any opening comments.
Great. Thank you, Salveen. Good morning, everyone. And thank you, Goldman, for the 43rd Healthcare Conference. That means I did my math. That means it must have started about when Gene Sykes graduated from college. So I know he's not here, so I can get away with that.
So listen, at Amgen, we always begin with patients. Our mission at Amgen, we're a mission-driven company, is to discover, develop, manufacture and distribute and deliver first-in-class and best-in-class medicines to patients all over the world. And the first quarter was a great indicator that we're on track to deliver against our long-term objectives and, more importantly, against
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |